These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 26112382)
1. C-kit is important for SOD1(G93A) mouse survival independent of mast cells. Staats KA; Schönefeldt S; Van Helleputte L; Van Rillaer M; Lampi Y; Dooley J; Van Den Bosch L; Liston A Neuroscience; 2015 Aug; 301():415-20. PubMed ID: 26112382 [TBL] [Abstract][Full Text] [Related]
2. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320 [TBL] [Abstract][Full Text] [Related]
3. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299 [TBL] [Abstract][Full Text] [Related]
4. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
5. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725 [TBL] [Abstract][Full Text] [Related]
6. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression. Apolloni S; Fabbrizio P; Amadio S; Volonté C J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088 [TBL] [Abstract][Full Text] [Related]
7. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261 [TBL] [Abstract][Full Text] [Related]
8. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice. Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790 [TBL] [Abstract][Full Text] [Related]
9. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539 [TBL] [Abstract][Full Text] [Related]
10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224 [TBL] [Abstract][Full Text] [Related]
11. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase. Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927 [TBL] [Abstract][Full Text] [Related]
12. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962 [TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056 [TBL] [Abstract][Full Text] [Related]
14. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease. Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008 [TBL] [Abstract][Full Text] [Related]
15. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice. Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896 [TBL] [Abstract][Full Text] [Related]
16. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915 [TBL] [Abstract][Full Text] [Related]
17. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis. Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555 [TBL] [Abstract][Full Text] [Related]
18. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1 Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164 [TBL] [Abstract][Full Text] [Related]
19. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Kim J; Kim TY; Cho KS; Kim HN; Koh JY Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729 [TBL] [Abstract][Full Text] [Related]
20. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. Zhao Z; Sui Y; Gao W; Cai B; Fan D J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]